Literature DB >> 12808081

Identification of a novel antigen of pathogenic Leptospira spp. that reacted with convalescent mice sera.

Nobuo Koizumi1, Haruo Watanabe1.   

Abstract

The virulence of leptospires isolated from human patients against C3H/HeJ mice was investigated. Infection with clinical isolates from patients with severe leptospirosis was lethal to C3H/HeJ mice, suggesting that C3H/HeJ mice are suitable as an acute lethal model of severe leptospirosis. Using this model, a novel antigen of pathogenic Leptospira spp. (named LAg42), which reacted with convalescent mice sera, was identified. LAg42 is a 42 kDa inner-membrane protein and its immunogenic region is located in the C-terminal region. The gene for LAg42 is conserved among pathogenic leptospires but not among non-pathogenic leptospires, which suggests its involvement in virulence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808081     DOI: 10.1099/jmm.0.05148-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  11 in total

1.  Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden.

Authors:  Suganya Viriyakosol; Michael A Matthias; Mark A Swancutt; Theo N Kirkland; Joseph M Vinetz
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

2.  Transbronchial Invasion and Proliferation of Leptospira interrogans in Lung without Inflammatory Cell Infiltration in a Hamster Model.

Authors:  Yasuhiko Nikaido; Midori Ogawa; Kazumasa Fukuda; Mitsuru Yokoyama; Takaaki Kanemaru; Toshiyuki Nakayama; Mitsumasa Saito
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

3.  LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata.

Authors:  David E Hoke; Suhelen Egan; Paul A Cullen; Ben Adler
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

4.  Proteome analysis of Leptospira interrogans virulent strain.

Authors:  Monica L Vieira; Daniel C Pimenta; Zenaide M de Morais; Silvio A Vasconcellos; Ana L T O Nascimento
Journal:  Open Microbiol J       Date:  2009-05-07

5.  Mouse model for sublethal Leptospira interrogans infection.

Authors:  Luciana Richer; Hari-Hara Potula; Rita Melo; Ana Vieira; Maria Gomes-Solecki
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

6.  Leptospiral hemolysins induce proinflammatory cytokines through Toll-like receptor 2-and 4-mediated JNK and NF-κB signaling pathways.

Authors:  Huan Wang; Yifei Wu; David M Ojcius; X Frank Yang; Chenglin Zhang; Shibiao Ding; Xu'ai Lin; Jie Yan
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

7.  Leptospirosis vaccines.

Authors:  Zhijun Wang; Li Jin; Alicja Wegrzyn
Journal:  Microb Cell Fact       Date:  2007-12-11       Impact factor: 5.328

8.  Complete Genome Sequences of Low-Passage Virulent and High-Passage Avirulent Variants of Pathogenic Leptospira interrogans Serovar Manilae Strain UP-MMC-NIID, Originally Isolated from a Patient with Severe Leptospirosis, Determined Using PacBio Single-Molecule Real-Time Technology.

Authors:  Kazuhito Satou; Makiko Shimoji; Hinako Tamotsu; Ayaka Juan; Noriko Ashimine; Misuzu Shinzato; Claudia Toma; Toshitsugu Nohara; Akino Shiroma; Kazuma Nakano; Kuniko Teruya; Yasunobu Terabayashi; Shun Ohki; Nobuo Koizumi; Shou Okano; Toshihiko Suzuki; Takashi Hirano
Journal:  Genome Announc       Date:  2015-08-13

9.  Comparison of Bacterial Burden and Cytokine Gene Expression in Golden Hamsters in Early Phase of Infection with Two Different Strains of Leptospira interrogans.

Authors:  Rie Fujita; Nobuo Koizumi; Hiromu Sugiyama; Rina Tomizawa; Ryoichi Sato; Makoto Ohnishi
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  Leptospira and inflammation.

Authors:  C F Gonçalves-de-Albuquerque; P Burth; A R Silva; M Younes-Ibrahim; H C Castro-Faria-Neto; M V Castro-Faria
Journal:  Mediators Inflamm       Date:  2012-10-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.